Cargando…
Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy
Cancer immunotherapy can significantly prevent tumor growth and metastasis by activating the autoimmune system without destroying normal cells. Although cancer immunotherapy has made some achievements in clinical cancer treatment, it is still restricted by systemic immunotoxicity, immune cell dysfun...
Autores principales: | Hu, Tingting, Huang, Yuezhou, Liu, Jing, Shen, Chao, Wu, Fengbo, He, Zhiyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383408/ https://www.ncbi.nlm.nih.gov/pubmed/37514008 http://dx.doi.org/10.3390/pharmaceutics15071821 |
Ejemplares similares
-
Biomimetic nanoparticles for tumor immunotherapy
por: Yu, Hanqing, et al.
Publicado: (2022) -
Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
por: Liu, Xinyi, et al.
Publicado: (2023) -
Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy
por: Wang, Tingting, et al.
Publicado: (2022) -
Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022) -
Recent progress in targeted delivery vectors based on biomimetic nanoparticles
por: Chen, Li, et al.
Publicado: (2021)